Genprex, Inc. (GNPX)

NasdaqCM • Currently down 0.02 (-0.50%) in today's trading session

1 member of Congress has disclosed 4 trades in Genprex, Inc. (GNPX) via STOCK Act filings. The most recent disclosure was a purchase by Tim Moore on 5 February 2026. Aggregate disclosed activity totals roughly $56.5K in purchases (midpoint estimates from bracketed disclosure amounts).

Genprex, Inc. is currently trading at $4.00, positioned at 0% of its 52-week range ($3.83 – $1210.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Portfolio

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$4.00
24h Change
-0.02 (-0.50%)
52 Week Range
$3.83—$1210.00
View on NASDAQ

Genprex, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for GNPX

Select to highlight on chart
4 transactions
Compliance: 100%
Tim Moore5 Feb 202620 Feb 2026PurchaseStock$1,001 - $15,000-91.77%
Tim Moore18 Dec 20257 Jan 2026PurchaseStock$1,001 - $15,000-92.16%
Tim Moore7 Nov 20252 Dec 2025PurchaseStock$1,001 - $15,000-96.12%
Tim Moore29 Oct 202512 Nov 2025PurchaseStock$15,001 - $50,000-97.40%

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$2.02M

Volume

68.86K

Beta

-0.89

P/E Ratio

-0.26

Fundamentals

EPS

$-15.29

Div. Yield

—

Open

$4.00

Day Range

$3.95 — $4.17

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Ryan Confer
IPO Date
2018-03-29
Website
www.genprex.com

Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leadi...

Earnings

Next Report

Q3 2026

2 Dec

EPS Est.

—

Rev. Est.

—

Days Until

98

Recent Quarters

Q2 202614 Aug
EPS$-9.40
Q1 202613 May
EPS$-14.07
Q4 202530 Mar
EPS$-25.30
Beat 91.2%
Q3 202514 Nov
EPS$-109.89
Beat 60.0%
Q2 20258 Aug
EPS$-187.00
Miss 1097.2%
Q1 202512 May
EPS$-285.71
Miss 411.3%
Q1 20251 Apr
EPS$-462.00
Miss 2461.0%
Q3 202413 Nov
EPS$-1351.65
Miss 8.8%
Q2 202421 Aug
EPS$-3300.00
Miss 6421.7%
Q1 202415 May
EPS$-4059.00
Miss 7163.8%
Q1 20241 Apr
EPS$-87.12
Miss 0.8%
Q3 202314 Nov
EPS$-5714.29
Miss 236027.7%
Q2 202321 Aug
EPS$-6593.41
Miss 5663.5%
Q1 202322 May
EPS$-8351.65
Miss 316250.4%
Q4 202231 Mar
EPS$-6593.41
Miss 5663.5%
Q3 202214 Nov
EPS$-114.40
Miss 4233.3%
Q2 202212 Aug
EPS$-4835.17
Miss 10.0%
Q1 202213 May
EPS$-5274.73
Miss 33.3%
Q4 202130 Mar
EPS$-5274.73
Miss 5894.0%
Q3 202115 Nov
EPS$-3076.92
Q2 202113 Aug
EPS$-3516.48
Miss 122853.9%
Q1 202117 May
EPS$-6153.85
Miss 233000.4%
Q4 202026 Mar
EPS$-6153.85
Miss 99800.2%
Q3 202012 Nov
EPS$-3076.92
Miss 66500.0%
Q2 202011 Aug
EPS$-5274.73
Beat 36.8%
Q1 202014 May
EPS$-8791.21
Miss 332900.4%
Q4 201930 Mar
EPS$-6153.85
Q3 201914 Nov
EPS$-6593.41
Beat 31.8%
Q2 201913 Aug
EPS$-10549.45
Miss 14.3%
Q1 201915 May
EPS$-6153.85
Beat 39.1%
Q1 20191 Apr
EPS$-10109.89
Miss 27.8%
Q3 201814 Nov
EPS$-3.30
Miss 15.4%
Q2 201814 Aug
EPS$-19789.00
Q1 201815 May
EPS$-2607.00
Q4 201729 Mar
EPS$-2552.00
Q3 201727 Nov
EPS$-2717.00

2 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

16 Jul 2026Reverse Split
Ratio1:22
21 Oct 2025Reverse Split
Ratio1:50
2 Feb 2024Reverse Split
Ratio1:40

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

CNC

Centene Corporation

47
$65.00-0.65 (-0.99%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

TNA

Direxion Daily Small Cap Bull 3X Shares

30
$72.55+0.88 (+1.23%)
Financial Services
Held by same politician
Significant holdings value
1 politician
View Stock

AAL

American Airlines Group Inc.

17
$13.95+0.32 (+2.35%)
Industrials
Held by same politician
1 politician
View Stock

Frequently Asked Questions about GNPX

Which members of Congress have traded GNPX?
1 member of Congress has disclosed 4 trade in Genprex, Inc. (GNPX) under the STOCK Act: Tim Moore.
When was GNPX most recently disclosed by Congress?
The most recent GNPX disclosure was a purchase by Tim Moore on 5 February 2026.
What is the total disclosed congressional trading volume for GNPX?
Members of Congress have disclosed approximately $56.5K in GNPX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in GNPX?
This GNPX page updates as soon as new STOCK Act disclosures are filed for Genprex, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.